GovChime
Notice ID: d5d41b4868e442a8b06dd1fd4a373f8cPresolicitationArchived

Renewal of licensing fee for the transgenic mouse strain, B-hIL2RA

Archived on June 8, 2026. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
9:00 AM EDT
Posted
May 28, 2026
Notice type
Presolicitation
Set-aside
No Set aside used
Agency
Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH

Notice details

Office
NATIONAL INSTITUTES OF HEALTH OLAO
Place of performance
Maryland, 20892
Last updated
Oct 30, 2026
First published
Last updated on SAM.gov

Identifiers

Solicitation number
75N98026Q00467
Notice ID
d5d41b4868e442a8b06dd1fd4a373f8c

Description

The MIB is conducting pre-clinical research on photoimmunotherapy (PIT), a targeted treatment approach that uses light activation to destroy specific cells. One area of this research focuses on IL2RA, a protein expressed on regulatory T cells (Tregs). These cells can reduce the immune system’s ability to respond effectively to cancer. The objective of this work is to selectively eliminate IL2RA-expressing Tregs in order to improve anti-cancer immune responses. 

To support this research, MIB uses a transgenic mouse strain known as B-hIL2RA, which expresses the human form of IL2RA rather than the mouse form. Use of this model is essential because it enables evaluation of the same treatment materials, including antibodies, that are intended for future human application. As a result, this mouse strain has proven invaluable in the MIB’s ongoing research program. 

The MIB is requesting to renew a licensing fee for transgenic mice, B-hIL2RA. B-hIL2RA transgenic mice.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Contracting Officer

Primary Contact

Documents

Files (1)

  • Requirements.docx

    15 KBAdded in Presolicitation version 3Posted
    Download

Lifecycle

  1. 3
    Version 3PresolicitationArchivedCurrent

    Renewal of licensing fee for the transgenic mouse strain, B-hIL2RA

    Notice d5d41b4868e442a8b06dd1fd4a373f8c on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

75N98026Q00467

Archive Date

Jun 8, 2026

Office Address

BETHESDA, MD, 20892